Cyclosporin clinical pharmacokinetics

Area of Science:

• Pharmacology
• Immunology
• Drug Metabolism

Background:

• Cyclosporin is a vital immunosuppressive drug for transplantation and autoimmune diseases.
• Its bioavailability is affected by lipophilicity, food, bile, and drug interactions.
• Hepatic metabolism via cytochrome P450 3A exhibits significant interindividual variability.

Purpose of the Study:

• To review the pharmacokinetic variability of cyclosporin.
• To discuss factors influencing cyclosporin distribution, metabolism, and elimination.
• To highlight the need for further research on cyclosporin metabolites.

Main Methods:

• Literature review of cyclosporin pharmacokinetics.
• Analysis of factors affecting drug absorption, distribution, metabolism, and excretion.
• Discussion of analytical methods and their impact on variability.

Main Results:

• Cyclosporin's pharmacokinetic parameters are highly variable, influenced by age, patient condition, transplant type, and comedication.
• Distribution is affected by physicochemical properties and carriers like lipoproteins and erythrocytes.
• Metabolism and metabolite activity, including renal effects, are not fully elucidated.

Conclusions:

• Cyclosporin dosing requires individualization due to significant pharmacokinetic variability.
• Standardized analytical methods may reduce variability in monitoring blood concentrations.
• Further studies are crucial to correlate metabolite pharmacokinetics with their clinical activity and adverse effects.